Earli Inc

Earli Inc. is a privately held company based in South San Francisco, California. With 36 employees, the company focuses on developing innovative solutions in the biotechnology sector. Earli specializes in a groundbreaking technology called Synthetic Biopsy, which utilizes gene therapy to induce cancer cells to produce a synthetic, non-human biomarker. This biomarker allows for precise localization of cancer within a PET scanner, providing a more effective and targeted approach to cancer detection and treatment. Earli's approach distinguishes itself from traditional biomarker-based methods, which often rely on cancer cells naturally producing detectable markers, which may not always be present. This innovative technology has garnered significant attention from prominent investors, including Andreessen Horowitz's Bio Fund, Khosla Ventures, Perceptive Advisors, Casdin Capital, Sands Capital, Marc Benioff, Menlo Ventures, and ZhenFund. Interested parties can visit Earli's website at earli.com for further information.